Free Trial
→ Ticker Revealed: Pre-IPO Access to 'Next Elon Musk' Company (From Banyan Hill Publishing) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AquaBounty Technologies, Inc. stock logo
AQB
AquaBounty Technologies
$1.04
+0.5%		$1.15
$0.77
▼
$1.97
$5.33M1.4898,166 shs83,519 shs
Cardio Diagnostics Holdings, Inc. stock logo
CDIO
Cardio Diagnostics
$1.67
-4.6%		$1.92
$0.97
▼
$7.91
$5.18M2.2931,899 shs31,907 shs
Creative Medical Technology Holdings, Inc. stock logo
CELZ
Creative Medical Technology
$0.77
-5.8%		$1.04
$0.62
▼
$6.25
$5.41M2.061.23 million shs167,365 shs
Valion Bio, Inc. Common Stock stock logo
VBIO
Valion Bio, Inc. Common Stock
$1.45
-6.5%		$3.23
$1.44
▼
$75.50
$1.38M1.83.49 million shs160,081 shs
10 Stocks Powering The Next AI Boom Cover
10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AquaBounty Technologies, Inc. stock logo
AQB
AquaBounty Technologies
+0.48%+12.62%-9.57%+7.22%-44.39%
Cardio Diagnostics Holdings, Inc. stock logo
CDIO
Cardio Diagnostics
-4.57%-14.80%-19.32%-1.18%-62.81%
Creative Medical Technology Holdings, Inc. stock logo
CELZ
Creative Medical Technology
-5.81%-13.13%-12.03%-10.20%-77.74%
Valion Bio, Inc. Common Stock stock logo
VBIO
Valion Bio, Inc. Common Stock
-6.45%-33.79%-30.95%-88.12%-98.07%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AquaBounty Technologies, Inc. stock logo
AQB
AquaBounty Technologies
$1.04
+0.5%		$1.15
$0.77
▼
$1.97
$5.33M1.4898,166 shs83,519 shs
Cardio Diagnostics Holdings, Inc. stock logo
CDIO
Cardio Diagnostics
$1.67
-4.6%		$1.92
$0.97
▼
$7.91
$5.18M2.2931,899 shs31,907 shs
Creative Medical Technology Holdings, Inc. stock logo
CELZ
Creative Medical Technology
$0.77
-5.8%		$1.04
$0.62
▼
$6.25
$5.41M2.061.23 million shs167,365 shs
Valion Bio, Inc. Common Stock stock logo
VBIO
Valion Bio, Inc. Common Stock
$1.45
-6.5%		$3.23
$1.44
▼
$75.50
$1.38M1.83.49 million shs160,081 shs
10 Stocks Powering The Next AI Boom Cover
10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AquaBounty Technologies, Inc. stock logo
AQB
AquaBounty Technologies
+0.48%+12.62%-9.57%+7.22%-44.39%
Cardio Diagnostics Holdings, Inc. stock logo
CDIO
Cardio Diagnostics
-4.57%-14.80%-19.32%-1.18%-62.81%
Creative Medical Technology Holdings, Inc. stock logo
CELZ
Creative Medical Technology
-5.81%-13.13%-12.03%-10.20%-77.74%
Valion Bio, Inc. Common Stock stock logo
VBIO
Valion Bio, Inc. Common Stock
-6.45%-33.79%-30.95%-88.12%-98.07%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AquaBounty Technologies, Inc. stock logo
AQB
AquaBounty Technologies
1.00
SellN/AN/A
Cardio Diagnostics Holdings, Inc. stock logo
CDIO
Cardio Diagnostics
1.00
SellN/AN/A
Creative Medical Technology Holdings, Inc. stock logo
CELZ
Creative Medical Technology
2.00
HoldN/AN/A
Valion Bio, Inc. Common Stock stock logo
VBIO
Valion Bio, Inc. Common Stock
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest VBIO, CELZ, AQB, and CDIO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/24/2026
Creative Medical Technology Holdings, Inc. stock logo
CELZ
Creative Medical Technology
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
DowngradeSell (D-) ➝ Sell (E+)
9/14/2026
AquaBounty Technologies, Inc. stock logo
AQB
AquaBounty Technologies
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
UpgradeSell (E+) ➝ Sell (D-)
9/10/2026
Creative Medical Technology Holdings, Inc. stock logo
CELZ
Creative Medical Technology
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
UpgradeSell (E+) ➝ Sell (D-)
9/8/2026
Cardio Diagnostics Holdings, Inc. stock logo
CDIO
Cardio Diagnostics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingSell (E+)
8/28/2026
AquaBounty Technologies, Inc. stock logo
AQB
AquaBounty Technologies
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
DowngradeSell (D-) ➝ Sell (E+)
8/27/2026
Creative Medical Technology Holdings, Inc. stock logo
CELZ
Creative Medical Technology
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
DowngradeSell (D-) ➝ Sell (E+)
8/20/2026
Creative Medical Technology Holdings, Inc. stock logo
CELZ
Creative Medical Technology
Roth Capital logo
Roth Capital
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingBuy
8/13/2026
Creative Medical Technology Holdings, Inc. stock logo
CELZ
Creative Medical Technology
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
UpgradeSell (E+) ➝ Sell (D-)
8/12/2026
AquaBounty Technologies, Inc. stock logo
AQB
AquaBounty Technologies
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
UpgradeSell (E+) ➝ Sell (D-)
7/31/2026
Creative Medical Technology Holdings, Inc. stock logo
CELZ
Creative Medical Technology
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
DowngradeSell (D-) ➝ Sell (E+)
7/17/2026
Valion Bio, Inc. Common Stock stock logo
VBIO
Valion Bio, Inc. Common Stock
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingSell (E+)
(Data available from 10/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AquaBounty Technologies, Inc. stock logo
AQB
AquaBounty Technologies
N/AN/AN/AN/A($0.49) per shareN/A
Cardio Diagnostics Holdings, Inc. stock logo
CDIO
Cardio Diagnostics
$10K494.32N/AN/A$3.82 per share0.44
Creative Medical Technology Holdings, Inc. stock logo
CELZ
Creative Medical Technology
$3K1,697.26N/AN/A$2.04 per share0.38
Valion Bio, Inc. Common Stock stock logo
VBIO
Valion Bio, Inc. Common Stock
$780K1.65N/AN/A$166.26 per share0.01
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AquaBounty Technologies, Inc. stock logo
AQB
AquaBounty Technologies
-$18.49M-$0.82N/AN/AN/AN/A-147.07%-28.73%11/10/2026 (Estimated)
Cardio Diagnostics Holdings, Inc. stock logo
CDIO
Cardio Diagnostics
-$6.50M-$2.92N/AN/AN/A-43,133.33%-82.28%-76.03%11/6/2026 (Estimated)
Creative Medical Technology Holdings, Inc. stock logo
CELZ
Creative Medical Technology
-$5.99M-$2.07N/AN/AN/AN/A-86.52%-81.96%11/6/2026 (Estimated)
Valion Bio, Inc. Common Stock stock logo
VBIO
Valion Bio, Inc. Common Stock
-$8.88M-$159.25N/AN/AN/AN/A-193.17%-67.10%N/A

Latest VBIO, CELZ, AQB, and CDIO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/10/2026N/A
AquaBounty Technologies, Inc. stock logo
AQB
AquaBounty Technologies
-$1.30N/AN/AN/A$0.27 millionN/A
11/6/2026N/A
Creative Medical Technology Holdings, Inc. stock logo
CELZ
Creative Medical Technology
-$0.24N/AN/AN/AN/AN/A
8/7/2026Q2 2026
Cardio Diagnostics Holdings, Inc. stock logo
CDIO
Cardio Diagnostics
N/A-$0.51N/A-$0.51N/A$0.01 million
8/7/2026Q2 2026
Creative Medical Technology Holdings, Inc. stock logo
CELZ
Creative Medical Technology
-$0.39-$0.41-$0.02-$0.41N/AN/A
8/6/2026Q2 2026
AquaBounty Technologies, Inc. stock logo
AQB
AquaBounty Technologies
N/A-$0.26N/A-$0.32N/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
AquaBounty Technologies, Inc. stock logo
AQB
AquaBounty Technologies
N/AN/AN/AN/AN/A
Cardio Diagnostics Holdings, Inc. stock logo
CDIO
Cardio Diagnostics
N/AN/AN/AN/AN/A
Creative Medical Technology Holdings, Inc. stock logo
CELZ
Creative Medical Technology
N/AN/AN/AN/AN/A
Valion Bio, Inc. Common Stock stock logo
VBIO
Valion Bio, Inc. Common Stock
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AquaBounty Technologies, Inc. stock logo
AQB
AquaBounty Technologies
N/A
4.26
4.26
Cardio Diagnostics Holdings, Inc. stock logo
CDIO
Cardio Diagnostics
N/A
17.16
17.16
Creative Medical Technology Holdings, Inc. stock logo
CELZ
Creative Medical Technology
N/A
12.90
12.90
Valion Bio, Inc. Common Stock stock logo
VBIO
Valion Bio, Inc. Common Stock
1.74
1.11
0.86

Institutional Ownership

CompanyInstitutional Ownership
AquaBounty Technologies, Inc. stock logo
AQB
AquaBounty Technologies
8.92%
Cardio Diagnostics Holdings, Inc. stock logo
CDIO
Cardio Diagnostics
8.06%
Creative Medical Technology Holdings, Inc. stock logo
CELZ
Creative Medical Technology
1.42%
Valion Bio, Inc. Common Stock stock logo
VBIO
Valion Bio, Inc. Common Stock
4.25%

Insider Ownership

CompanyInsider Ownership
AquaBounty Technologies, Inc. stock logo
AQB
AquaBounty Technologies
1.02%
Cardio Diagnostics Holdings, Inc. stock logo
CDIO
Cardio Diagnostics
8.99%
Creative Medical Technology Holdings, Inc. stock logo
CELZ
Creative Medical Technology
1.00%
Valion Bio, Inc. Common Stock stock logo
VBIO
Valion Bio, Inc. Common Stock
2.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
AquaBounty Technologies, Inc. stock logo
AQB
AquaBounty Technologies
35.15 million5.10 millionNo Data
Cardio Diagnostics Holdings, Inc. stock logo
CDIO
Cardio Diagnostics
172.96 million2.69 millionNot Optionable
Creative Medical Technology Holdings, Inc. stock logo
CELZ
Creative Medical Technology
46.59 million6.53 millionNot Optionable
Valion Bio, Inc. Common Stock stock logo
VBIO
Valion Bio, Inc. Common Stock
10890,000866,000Not Optionable

Recent News About These Companies

With Section 232 Tariffs Reshaping Biotech, Valion Bio’s Velocity Bioworks Capitalizes on Domestic CDMO Surge
October 14 at 1:27 PM  |  biospace.comB
With Section 232 Tariffs Reshaping Biotech, Valion Bio's Velocity Bioworks Capitalizes on Domestic CDMO Surge
October 14 at 8:15 AM  |  accessnewswire.comA
Valion Bio, Inc. Common Stock (NASDAQ:VBIO) Shares Shorted: Short Interest Up 128.9% in September
October 13 at 7:01 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31114621
Valion Bio (NASDAQ: VBIO) lines up $50,000 Series B financing step
October 11, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31107389
Valion Bio (Nasdaq:VBIO): Oral Mucosal Entolimod Could Offer a New Needle-Free Deployment Path to Support Growing Need for Scalable Civilian Radiation Preparedness Should ...
October 9, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/markets-news/ACCESS/5323814/valion-bio-nasdaqvbio-oral-mucosal-entolimod-could-offer-a-new-needle-free-deployment-path-to-support-growing-need-for-scalable-civilian-radiation-preparedness-should-nuclear-infrastructure-expand-to-support-data-centers/
Valion Bio (Nasdaq:VBIO): Oral Mucosal Entolimod Could Offer a New Needle-Free Deployment Path to Support Growing Need for Scalable Civilian Radiation Preparedness Should Nuclear Infrastructure Expand to Support Data Centers
October 9, 2026  |  accessnewswire.comA
Valion Bio (NASDAQ: VBIO) taps Jensen to steer Entolimod with $35.6 million
October 8, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31097816
Valion Chair Jensen Outlines Focus On Entolimod Development; Stock Down
October 6, 2026  |  rttnews.comhttps://www.rttnews.com/3696546/valion-chair-jensen-outlines-focus-on-entolimod-development-stock-down.aspx
New Valion Bio Board Chair Thomas Jensen Brings Biotech Turnaround Experience to the Advancement of Entolimod
October 5, 2026  |  accessnewswire.comA
Valion Bio and Shear Kershman Laboratories Successfully Formulate Oral Mucosal Entolimod; Valion Sees Potential for Multi-Fold Expansion of Long-Term Opportunity
September 30, 2026  |  accessnewswire.comA
Valion Bio, Inc. Announces Appointment of Dean Zikria as Interim Chief Executive Officer
September 25, 2026  |  marketscreener.comM
Valion Appoints Life Sciences Veteran Dean Zikria as Interim CEO and Announces Board Leadership Transitions
September 23, 2026  |  accessnewswire.comA
Valion Bio, Inc.: Valion Bio Regains Compliance with NASDAQ Minimum Bid Price Listing Rule
September 23, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-09/69644124-valion-bio-inc-valion-bio-regains-compliance-with-nasdaq-minimum-bid-price-listing-rule-200.htm
Valion Bio Regains Compliance with NASDAQ Minimum Bid Price Listing Rule
September 22, 2026  |  accessnewswire.comA
VBIO - Valion Bio, Inc.
September 10, 2026  |  seekingalpha.comhttps://seekingalpha.com/symbol/VBIO/historical-price-quotes
Valion Bio Announces Changes to Management and Board of Directors
September 1, 2026  |  accessnewswire.comA
Valion Bio's Reverse Stock Split Takes Effect Today, August 31, 2026; Stock Up
August 31, 2026  |  rttnews.comhttps://www.rttnews.com/3687070/valion-bio-s-reverse-stock-split-takes-effect-today-august-31-2026-stock-up.aspx
Valion Bio, Inc.: Valion Bio Announces Reverse Stock Split
August 27, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-08/69425881-valion-bio-inc-valion-bio-announces-reverse-stock-split-200.htm
Valion Bio Inc VBIO
August 25, 2026  |  morningstar.comM
Valion Bio, Inc. (VBIO)
August 19, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/quote/VBIO/key-statistics/

New MarketBeat Followers Over Time

Media Sentiment Over Time

AquaBounty Technologies stock logo

AquaBounty Technologies NASDAQ:AQB

$1.04 +0.01 (+0.48%)
As of 10/14/2026 04:00 PM Eastern

AquaBounty Technologies, Inc., a biotechnology company, operates in the aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It also operates salmon farms using proprietary technology. In addition, the company offers AquAdvantage Salmon, a genetically engineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was incorporated in 1991 and is headquartered in Harvard, Massachusetts.

Cardio Diagnostics stock logo

Cardio Diagnostics NASDAQ:CDIO

$1.67 -0.08 (-4.57%)
Closing price 10/14/2026 04:00 PM Eastern
Extended Trading
$1.68 +0.01 (+0.66%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.

Creative Medical Technology stock logo

Creative Medical Technology NASDAQ:CELZ

$0.77 -0.05 (-5.81%)
Closing price 10/14/2026 04:00 PM Eastern
Extended Trading
$0.77 -0.01 (-0.69%)
As of 04:40 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Creative Medical Technology Holdings, Inc., a commercial stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; and StemSpine, a regenerative stem cell procedure to treat degenerative disc disease. It also develops ImmCelz, an immunotherapy platform for multiple diseases; OvaStem for treatment of female infertility; CELZ-201 to treat Type 1 diabetes; AlloStemSpine for the treatment of chronic lower back pain; and Alova to treat infertility as a result of premature ovarian failure. In addition, the company develops products and services for various indications, including preventing the rejection of transplanted organs, kidney failure, liver failure, heart attack, and Parkinson's disease. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.

Valion Bio, Inc. Common Stock stock logo

Valion Bio, Inc. Common Stock NASDAQ:VBIO

$1.45 -0.10 (-6.45%)
As of 10/14/2026 04:00 PM Eastern

Tivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas